Klebsiella pneumoniae

"Klebsiella pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.

Descriptor ID	D007711
MeSH Number(s)	B03.440.450.425.425.600 B03.660.250.150.400.590
Concept/Terms	Klebsiella pneumoniae Klebsiella pneumoniae Klebsiella rhinoscleromatis Klebsiella rhinoscleromatis

Below are MeSH descriptors whose meaning is more general than "Klebsiella pneumoniae".

Organisms [B]
Bacteria [B03]
Gram-Negative Bacteria [B03.440]
Gram-Negative Facultatively Anaerobic Rods [B03.440.450]
Enterobacteriaceae [B03.440.450.425]
Klebsiella [B03.440.450.425.425]
Klebsiella pneumoniae [B03.440.450.425.425.600]
Proteobacteria [B03.660]
Gammaproteobacteria [B03.660.250]
Enterobacteriaceae [B03.660.250.150]
Klebsiella [B03.660.250.150.400]
Klebsiella pneumoniae [B03.660.250.150.400.590]

Below are MeSH descriptors whose meaning is related to "Klebsiella pneumoniae".

Below are MeSH descriptors whose meaning is more specific than "Klebsiella pneumoniae".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Klebsiella pneumoniae" by people in this website by year, and whether "Klebsiella pneumoniae" was a major or minor topic of these publications.

Bar chart showing 23 publications over 13 distinct years, with a maximum of 3 publications in 2004 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	0	1	1
2004	2	1	3
2006	0	1	1
2010	1	0	1
2011	0	1	1
2013	1	1	2
2016	1	2	3
2017	0	2	2
2018	2	0	2
2019	1	1	2
2021	0	2	2
2022	1	1	2
2023	0	1	1

Below are the most recent publications written about "Klebsiella pneumoniae" by people in Profiles.

Luterbach CL, Chen L, Komarow L, Ostrowsky B, Kaye KS, Hanson B, Arias CA, Desai S, Gallagher JC, Novick E, Pagkalinawan S, Lautenbach E, Wortmann G, Kalayjian RC, Eilertson B, Farrell JJ, McCarty T, Hill C, Fowler VG, Kreiswirth BN, Bonomo RA, van Duin D. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals. Clin Infect Dis. 2023 Jan 13; 76(2):229-237.

View in: PubMed
Karlowsky JA, Lob SH, Khan A, Chen WT, Woo PCY, Seto WH, Ip M, Leung S, Wong QW, Chau RWY, DeRyke CA, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019. J Med Microbiol. 2022 Apr; 71(4).

View in: PubMed
Karlowsky JA, Lob SH, DeRyke CA, Siddiqui F, Young K, Motyl MR, Sahm DF. Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019. Int J Antimicrob Agents. 2022 Mar; 59(3):106535.

View in: PubMed
Crane AB, Abreu Diaz MC, Jiang Y, Pergament KM. Rare case of endogenous Klebsiella endophthalmitis associated with emphysematous prostatitis in a patient with diabetes, cirrhosis and COVID-19. BMJ Case Rep. 2021 Apr 21; 14(4).

View in: PubMed
Karlowsky JA, Lob SH, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019. BMC Microbiol. 2021 03 06; 21(1):74.

View in: PubMed
Karlowsky JA, Kazmierczak KM, Young K, Motyl MR, Sahm DF. In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum ?-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016). Diagn Microbiol Infect Dis. 2020 Apr; 96(4):114925.

View in: PubMed
Al Rahmany D, Albeloushi A, Alreesi I, Alzaabi A, Alreesi M, Pontiggia L, Ghazi IM. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. Int J Infect Dis. 2019 Jun; 83:77-82.

View in: PubMed
Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-?-lactamase-producing isolates (SIDERO-WT-2014 Study). Int J Antimicrob Agents. 2019 Feb; 53(2):177-184.

View in: PubMed
Wise MG, Horvath E, Young K, Sahm DF, Kazmierczak KM. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. J Med Microbiol. 2018 Mar; 67(3):289-295.

View in: PubMed
Lob SH, Hackel MA, Kazmierczak KM, Young K, Motyl MR, Karlowsky JA, Sahm DF. In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program). Antimicrob Agents Chemother. 2017 06; 61(6).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement